Tryg is one of the highest-quality P&C insurers in the world: leading positions across Denmark, Norway and Sweden, with the scale, brand and claims data to run a best-in-class combined ratio of 80.3% (claims 66.9% + expense 13.4%), improved again year-on-year. The investment portfolio is deliberately de-risked into Scandinavian covered bonds (a ~1.3% yield), so — unlike a Berkshire-style float compounder — the equity story is pure underwriting plus distribution, not investment leverage. ROE is ~13.7% on a 196% solvency ratio, with a ~5.5% growing dividend and a DKK 1bn buyback.

The franchise is elite; the price is the problem. At 2.30x book, 16.3x earnings (P/TBV is meaningless — goodwill is ~80% of equity from the Trygg-Hansa/Codan deals), the stock sits ~24% above a Gordon fair P/B of ~1.86x (fair ~DKK 120 on a 13.7% ROE and an ~8.75% cost of equity). You are paying a premium for underwriting consistency and dividend reliability — both real, but fully discounted.

Gordon fair P/B = (ROE−g)/(COE−g) with COE 8.75%, g 3% and ROE 13.7% gives ~1.86x → fair value ~DKK 120 on a Q1 BVPS of ~64. Current 2.30x book / 16.3x earnings (~24% premium).

Base DKK 130 (a premium to fair P/B for best-in-class underwriting + dividend reliability, but below the current price); bull DKK 160 if the sub-81% combined ratio + premium growth + buyback sustain a 14%+ ROE; bear DKK 110 toward a normal-cycle combined ratio + multiple de-rating.

The operating reverse-DCF (NOPAT / invested capital / WACC) does not apply to a balance-sheet business — leverage is the raw material and "net debt" is not meaningful. The equity is valued on residual income: book equity plus the present value of returns above the cost of equity, discounted at K_e; the single-stage lens is the Gordon fair price-to-book, (ROE−g)/(K_e−g). The market prices in a sustainable ROE of 15.8% vs 13.6% currently earned; at a sustained 13.6% ROE the warranted P/B is 1.85× (DKK 123/sh, -17%).

Sensitivity — fair value / share at K_e × ROE

Green = fair value above the current price of DKK 147.90. For a financial the surface is dominated by cost of equity and sustainable ROE — not unit growth.

⤓ Download the full model (.xlsx) — formula-driven sheets; flex the blue input cells and the model cascades in Excel.

1. Best-in-class underwriting

80.3% combined ratio — the lowest in the Nordic cohort, improving YoY.

2. Pricing power

Scale + data let Tryg push price ahead of claims inflation.

3. Reliable dividend

~5.5% growing dividend + DKK 1bn buyback on 196% solvency.

4. Premium growth

GWP +3.8% local currency on a resilient Nordic base.

• Full valuation2.30x book vs ~1.86x Gordon fair — ~24% premium; no margin of safety.
• Combined-ratio normalisationAn 80% combined ratio is exceptional; mean-reversion toward 84-85% cuts ROE.
• Claims inflation / nat-catWeather and claims-inflation spikes pressure the loss ratio.
• Minimal investment leverageThe de-risked float means little upside from rising yields.

Tryg is an elite, wide-moat Scandinavian P&C underwriter (80.3% combined ratio, 196% solvency, reliable ~5.5% dividend) — but at 2.30x book it trades ~24% above a Gordon fair P/B of ~1.86x (fair ~DKK 120). HOLD, lean reduce; base DKK 130.

A superb business at a full price; accumulate only on a meaningful de-rate where the underwriting quality and dividend are no longer fully paid for.

Every adjustment traces to the cited note/page in the source filing — click to open it there. Annual report / 10-K: 📄 open  ·  Latest interim: 📄 open

How the mttssn view has evolved — each prior dated note is preserved.

• 2026-06-15 · HOLD/MEDIUM · Streamlined — this version
• 2026-06-08 · HOLD/MEDIUM · Streamlined
• 2026-05-31 · Buy/medium